How nontraditional founders can overcome bias in angel investor chemistry
“The there's one thing you mentioned here, which is this issue of chemistry.”
Okay. The there's one thing you mentioned here, which is this issue of chemistry. Right? Early stage, you don't have a lot of hard data. Chemistry is so important for angels. But chemistry is also the place where bias can thrive. So if I'm a, I don't know, a nontraditional founder, and I'm trying to make inroads and get funding for a very nontraditional kind of business, how do I balance that chemistry with this possibility of bias, especially with angel groups? Any advice?
About this clip
A discussion about the double-edged nature of 'chemistry' in early-stage fundraising. The clip explores how chemistry is crucial for angel investments but can also be where unconscious bias thrives, particularly affecting nontraditional founders and businesses seeking funding.
Why this clip
Addresses a critical tension in early-stage fundraising that many founders face but rarely gets discussed openly.
What they said next
You're only as good as your last board meeting
24:12 - 25s · personal lesson
More from this episode
Similar clips from other shows
From the blog
Want clips like this for your podcast?
We find your top 5-8 clips, write the hooks, and deliver ready-to-post content. First 2 episodes are free.
Get 2 Episodes Clipped Free